{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:08:19Z","timestamp":1792591699586,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ajog.2017.02.027","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T01:32:43Z","timestamp":1487727163000},"page":"129-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":433,"title":["Ovarian reserve testing: a user\u2019s guide"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-9904","authenticated-orcid":false,"given":"Reshef","family":"Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.02.027_bib1","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and\u00a0interpreting measures of ovarian reserve: a\u00a0committee opinion","volume":"103","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib2","doi-asserted-by":"crossref","first-page":"818912","DOI":"10.1155\/2013\/818912","article-title":"Potential mechanisms for racial and ethnic differences in antim\u00fcllerian hormone and ovarian reserve","volume":"2013","author":"Tal","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.ajog.2017.02.027_bib3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antim\u00fcllerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib5","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.fertnstert.2013.03.001","article-title":"Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antim\u00fcllerian hormone","volume":"99","author":"Toner","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/GCO.0000000000000175","article-title":"Ovarian response biomarkers: physiology and performance","volume":"27","author":"Iliodromiti","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.027_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0015-0282(16)53707-8","article-title":"Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in\u00a0vitro fertilization","volume":"54","author":"Scott","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/humrep\/deh119","article-title":"Intercycle variability of ovarian reserve tests: results of a prospective randomized study","volume":"19","author":"Kwee","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.fertnstert.2007.10.028","article-title":"Establishing the intercycle variability of three-dimensional ultrasonographic predictors of ovarian reserve","volume":"90","author":"Jayaprakasan","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib10","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0002-9378(98)70087-0","article-title":"The detection of diminished ovarian reserve in infertile women","volume":"179","author":"Sharara","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.027_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in\u00a0vitro fertilization outcome","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle-stimulating hormone levels on cycle day 3 are predictive of in\u00a0vitro fertilization outcome","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib13","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in\u00a0vitro fertilization performance than age","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/17.1.118","article-title":"A\u00a0moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women","volume":"17","author":"Esposito","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A\u00a0systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2004.06.062","article-title":"Taking a basal follicle-stimulating hormone history is essential before initiating in\u00a0vitro fertilization","volume":"83","author":"Roberts","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib17","first-page":"711","article-title":"Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid mullerian-inhibiting substance and androgen content","volume":"76","author":"Seifer","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0092-8674(94)90251-8","article-title":"Mullerian-inhibiting substance function during mammalian sexual development","volume":"79","author":"Behringer","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ajog.2017.02.027_bib20","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-mullerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2017.02.027_bib21","first-page":"3836","article-title":"Expression of anti-mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib22","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.fertnstert.2005.01.117","article-title":"The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in\u00a0vitro fertilization outcome in low responder patients: a pilot study","volume":"84","author":"Garcia-Velasco","year":"2005","journal-title":"Fertil Steril"},{"issue":"Suppl","key":"10.1016\/j.ajog.2017.02.027_bib23","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.fertnstert.2007.03.066","article-title":"Mullerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture","volume":"89","author":"Grossman","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib24","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajog.2017.02.027_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/humrep\/deh688","article-title":"High reproducibility of serum anti-mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status","volume":"20","author":"Fanchin","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib26","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib27","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib28","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/humrep\/dep366","article-title":"Comparison of inter- and intra-cycle variability of anti-mullerian hormone and antral follicle counts","volume":"25","author":"van Disseldorp","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.fertnstert.2007.04.054","article-title":"Statistically significant changes of antim\u00fcllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women","volume":"89","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib31","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.fertnstert.2009.07.1674","article-title":"Anti-mullerian hormone and inhibin B variability during normal menstrual cycles","volume":"94","author":"Sowers","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib32","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.fertnstert.2013.01.132","article-title":"Variation in antim\u00fcllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response","volume":"99","author":"Hadlow","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib33","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/humrep\/deu142","article-title":"Biological variability in serum anti-mullerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women","volume":"29","author":"Kissell","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.rbmo.2012.02.023","article-title":"Intra-cycle fluctuations of anti-mullerian hormone in normal women with a regular cycle: a re-analysis","volume":"24","author":"Overbeek","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/molehr\/gar059","article-title":"Data-driven assessment of the human ovarian reserve","volume":"18","author":"Kelsey","year":"2012","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib37","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-mullerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2017.02.027_bib38","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/humrep\/der182","article-title":"Anti-mullerian hormone-tailored stimulation protocols improve outcomes whilst reducing adverse effects and costs of IVF","volume":"26","author":"Yates","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib39","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.fertnstert.2012.07.1139","article-title":"Contribution of the rate of change of antim\u00fcllerian hormone in estimating time to menopause for late reproductive-age women","volume":"98","author":"Freeman","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib41","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","article-title":"Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women","volume":"97","author":"Freeman","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.fertnstert.2015.10.004","volume":"105","author":"Seifer","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib44","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib46","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2015-2474","article-title":"Is anti-mullerian hormone associated with fecundability? Findings from the EAGeR trial","volume":"100","author":"Zarek","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib47","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.rbmo.2011.06.011","article-title":"The journey from the old to the new AMH assay: how to avoid getting lost in the values","volume":"23","author":"Nelson","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-mullerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.fertnstert.2015.06.024","article-title":"Two new automated, compared with two enzyme-linked immunosorbent, antim\u00fcllerian hormone assays","volume":"104","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib50","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/humrep\/dev127","article-title":"Performance of the two new fully automated anti-mullerian hormone immunoassays compared with the clinical standard assay","volume":"30","author":"van Helden","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib51","unstructured":"FDA News. FDA Grants Clearance to\u00a0Roche's Anti-Mullerian Hormone Test Elecsys.\u00a0Available at: http:\/\/www.fdanews.com\/articles\/179932-fda-grants-clearance-to-roches-anti-mullerian-hormone-test-elecsys. Accessed March 27, 2017."},{"key":"10.1016\/j.ajog.2017.02.027_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.rbmo.2010.05.009","article-title":"Normal serum concentrations of anti-mullerian\u00a0hormone in women with regular menstrual cycles","volume":"21","author":"La Marca","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib53","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.fertnstert.2011.02.057","article-title":"Age-related normograms of serum antim\u00fcllerian hormone levels in a population of infertile women: a multicenter study","volume":"95","author":"Almog","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.rbmo.2010.12.002","article-title":"Utility of age-specific serum anti-mullerian hormone concentrations","volume":"22","author":"Barad","year":"2011","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib55","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.fertnstert.2010.10.011","article-title":"Age-specific serum anti-mullerian hormone values for 17,120 women presenting to fertility centers within the United States","volume":"95","author":"Seifer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","article-title":"Development of a nomogram based on markers of ovarian reserve for the individualization of the follicle-stimulating hormone starting dose in in\u00a0vitro fertilization cycles","volume":"119","author":"La Marca","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2017.02.027_bib57","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1600-0412.2012.01448.x","article-title":"Age-related distributions of anti-mullerian hormone level and anti-mullerian hormone models","volume":"91","author":"Lee","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2017.02.027_bib58","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2012-1440","article-title":"Serum anti-mullerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood","volume":"97","author":"Lie Fong","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jc.2005-2076","article-title":"Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome","volume":"91","author":"Pigny","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib60","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib61","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1016\/j.fertnstert.2011.05.051","article-title":"Serum antim\u00fcllerian hormone in healthy premenopausal women","volume":"95","author":"Shaw","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2012.09.001","article-title":"Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception","volume":"25","author":"Bentzen","year":"2012","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib63","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1210\/jc.2012-3995","article-title":"Reproductive and lifestyle determinants of anti-mullerian hormone in a large population-based study","volume":"98","author":"Dolleman","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib64","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.fertnstert.2012.11.034","article-title":"Antim\u00fcllerian hormone levels decrease in women using combined contraception independently of administration route","volume":"99","author":"Kallio","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib65","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.fertnstert.2014.05.026","article-title":"Antim\u00fcllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception","volume":"102","author":"Johnson","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib66","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/humupd\/dmu062","article-title":"Technical and performance characteristics of anti-mullerian hormone and antral follicle count as biomarkers of ovarian response","volume":"21","author":"Iliodromiti","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/humrep\/der435","article-title":"Individual serum levels of anti-mullerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study","volume":"27","author":"Hagen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib68","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S1472-6483(10)60561-5","article-title":"Active smoking compromises IVF outcome and affects ovarian reserve","volume":"16","author":"Freour","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib69","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/gme.0b013e3181c7deba","article-title":"The impact of smoking on antim\u00fcllerian hormone levels in women aged 38 to 50 years","volume":"17","author":"Plante","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2017.02.027_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.rbmo.2010.02.021","article-title":"Effect of cigarette smoking upon reproductive hormones in women of reproductive age: a retrospective analysis","volume":"20","author":"Waylen","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib71","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1210\/jc.2012-1213","article-title":"The level of serum anti-mullerian hormone correlates with vitamin D status in men and women but not in boys","volume":"97","author":"Dennis","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib72","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-012-2363-x","article-title":"Is there any correlation between AMH and obesity in premenopausal women?","volume":"286","author":"Sahmay","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2017.02.027_bib73","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1701-2163(16)34573-X","article-title":"Effect of obesity on parameters of ovarian reserve in premenopausal women","volume":"32","author":"Halawaty","year":"2010","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2017.02.027_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.contraception.2009.10.004","article-title":"Antim\u00fcllerian hormone and obesity: insights in oral contraceptive users","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.ajog.2017.02.027_bib75","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.fertnstert.2011.03.081","article-title":"Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with normal ovarian reserve","volume":"95","author":"Buyuk","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib76","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.fertnstert.2006.05.074","article-title":"Association of anti-mullerian hormone levels with obesity in late reproductive-age women","volume":"87","author":"Freeman","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib77","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/gme.0b013e318165981e","article-title":"Body size affects measures of ovarian reserve in late reproductive age women","volume":"15","author":"Su","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.ajog.2017.02.027_bib78","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.fertnstert.2013.09.015","article-title":"Race\/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race\/ethnic groups of healthy, regularly cycling women","volume":"101","author":"Bleil","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib79","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib80","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-Mullerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib81","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/humrep\/der318","article-title":"Xpect Investigators. Predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment","volume":"26","author":"Andersen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib82","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib83","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","article-title":"Predictors of ovarian response in women treated with corifollitropin alfa for in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"100","author":"Polyzos","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib84","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib85","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.fertnstert.2012.06.006","article-title":"High frequency of discordance between antim\u00fcllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the menstrual cycle from 5,354 women in US fertility centers","volume":"98","author":"Leader","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib86","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7827-8-64","article-title":"Discordances between follicle stimulating hormone (FSH) and anti-mullerian hormone (AMH) in female infertility","volume":"8","author":"Gleicher","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.ajog.2017.02.027_bib87","doi-asserted-by":"crossref","first-page":"e108493","DOI":"10.1371\/journal.pone.0108493","article-title":"Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilization who had discordant anti-mullerian hormone and antral follicle count measurements: a retrospective study","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2017.02.027_bib88","series-title":"Antim\u00fcllerian hormone: biology, role in ovarian function and clinical significance","year":"2016"},{"key":"10.1016\/j.ajog.2017.02.027_bib89","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone-stratified, dose-response trial in women undergoing in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib90","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/humrep\/den480","article-title":"Anti-mullerian hormone-based approach to controlled ovarian stimulation for assisted conception","volume":"24","author":"Nelson","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib91","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-mullerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijgo.2015.04.046","article-title":"A\u00a0systematic review and meta-analysis of metformin among patients with polycystic ovary syndrome undergoing assisted reproductive technology procedures","volume":"131","author":"Huang","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ajog.2017.02.027_bib93","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2017.02.027_bib94","article-title":"Utility of anti-mullerian hormone for predicting the time to final menstrual period: the Study of Women's Health Across the Nation (SWAN)","author":"Finkelstein","year":"2016","journal-title":"Endocrine Society Meeting"},{"key":"10.1016\/j.ajog.2017.02.027_bib95","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/humrep\/dew112","article-title":"Does anti-mullerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study","volume":"31","author":"Depmann","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib96","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.fertnstert.2013.03.014","article-title":"Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer","volume":"99","author":"Anderson","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib97","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","article-title":"Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib98","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","article-title":"Pretreatment antim\u00fcllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy","volume":"99","author":"Dillon","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib99","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajog.2017.02.027_bib100","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.28942","article-title":"Prechemotherapy antim\u00fcllerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients","volume":"120","author":"Su","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ajog.2017.02.027_bib101","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rbmo.2016.04.007","article-title":"The role of AMH in the pathophysiology of polycystic ovarian syndrome","volume":"33","author":"Garg","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ajog.2017.02.027_bib102","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antim\u00fcllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.027_bib103","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib104","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib105","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","article-title":"The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome","volume":"24","author":"Nardo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib106","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Antim\u00fcllerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib107","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/jc.2013-3781","article-title":"Increased androgen, anti-mullerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?","volume":"99","author":"Sjaarda","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2017.02.027_bib108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0015-0282(16)32587-0","article-title":"Reproductive span and rate of reproduction among Hutterite women","volume":"8","author":"Tietze","year":"1957","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib109","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/humupd\/8.2.141","article-title":"The variability of female reproductive aging","volume":"8","author":"te Velde","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/humupd\/dmr040","article-title":"ESHRE Reproduction and Society Task Force. Demographic and medical consequences of the postponement of parenthood","volume":"18","author":"Schmidt","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ajog.2017.02.027_bib111","first-page":"1","article-title":"Births: final data for 2012","volume":"62","author":"Martin","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2017.02.027_bib112","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.fertnstert.2011.08.018","article-title":"An assessment of female university students' attitudes toward screening technologies for ovarian reserve","volume":"96","author":"Bavan","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib113","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/humrep\/des409","article-title":"Age shock: misperceptions of the impact of age on fertility before and after IVF in women who conceived after age 40","volume":"28","author":"Mac Dougall","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib114","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10815-014-0415-9","article-title":"Knowledge of ovarian reserve and reproductive choices","volume":"32","author":"Azhar","year":"2015","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2017.02.027_bib115","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1093\/humrep\/der271","article-title":"Anti-mullerian hormone\u2013is it a crystal ball for predicting ovarian aging?","volume":"26","author":"Loh","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humrep\/der446","article-title":"Anti-mullerian hormone: clairvoyance or crystal clear?","volume":"27","author":"Nelson","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib117","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/humrep\/deu317","article-title":"Does oocyte banking for anticipated gamete exhaustion influence future relational and reproductive choices? A follow-up of bankers and non-bankers","volume":"30","author":"Stoop","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib118","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1093\/humrep\/deu265","article-title":"Ovarian reserve screening: a scientific and ethical analysis","volume":"29","author":"Tremellen","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib119","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","article-title":"Antim\u00fcllerian hormone as a predictor of natural fecundability in women aged 30-42 years","volume":"117","author":"Steiner","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.027_bib120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.fertnstert.2009.10.047","article-title":"Racial and ethnic differences in reproductive potential across the life cycle","volume":"93","author":"Butts","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib121","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum mullerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib122","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1177\/0961203311409272","article-title":"Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-muellerian hormone","volume":"20","author":"Lawrenz","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.ajog.2017.02.027_bib123","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.crohns.2012.03.003","article-title":"Serum anti-mullerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women","volume":"7","author":"Senates","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ajog.2017.02.027_bib124","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.fertnstert.2014.08.014","article-title":"BRCA1 germline mutations may be associated with reduced ovarian reserve","volume":"102","author":"Wang","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib125","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/humrep\/dew044","article-title":"Anti-mullerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations","volume":"31","author":"Phillips","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ajog.2017.02.027_bib126","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.fertnstert.2008.01.098","article-title":"A\u00a0pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-mullerian hormone","volume":"91","author":"Gleicher","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib127","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10815-014-0276-2","article-title":"AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level","volume":"31","author":"Pastore","year":"2014","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.ajog.2017.02.027_bib128","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.fertnstert.2010.06.010","article-title":"Serum anti-mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve","volume":"94","author":"Iwase","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.fertnstert.2009.02.022","article-title":"Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-mullerian hormone levels","volume":"94","author":"Chang","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2017.02.027_bib130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3109\/09513590903159615","article-title":"Anti muellerian hormone serum levels in women with endometriosis: a case-control study","volume":"25","author":"Shebl","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ajog.2017.02.027_bib131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejogrb.2013.10.003","article-title":"Evaluation of serum anti-mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis","volume":"172","author":"Pacchiarotti","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2017.02.027_bib132","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0002-9378(96)70333-2","article-title":"Antim\u00fcllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol","volume":"174","author":"Rey","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.02.027_bib133","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/hupa.2000.18498","article-title":"Anti-mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors","volume":"31","author":"Rey","year":"2000","journal-title":"Hum Pathol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817303009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817303009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:15:44Z","timestamp":1757589344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817303009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0002937817303009"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.027","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian reserve testing: a user\u2019s guide","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}